What Patients Value in Data Reuse for Oncology Research: A Multi-Stakeholder Qualitative Study to Inform the European Health Data Space Implementation in Belgium and Beyond

Key Takeaways

• Patients demand clear, granular consent for oncology data sharing.
• Trust rises when data security and anonymity are guaranteed.
• Perceived research benefit to future patients boosts participation willingness.
• Governance frameworks must embed patient voice to meet EHDS goals.

Pulse Analysis

The European Health Data Space (EHDS) represents a landmark effort to harmonize health data access across the EU, promising faster innovation in oncology research. Yet, the success of such a data ecosystem hinges on patient trust, which is built on transparent consent mechanisms and assurances that personal information remains secure and anonymized. This Belgian‑led qualitative study uncovers that patients are willing to share data when they see clear, tangible benefits for future cancer patients and when they retain granular control over how their information is used.

Beyond consent, the study emphasizes the strategic role of patient‑centered governance in the EHDS rollout. By integrating patient voices into policy design, regulators can pre‑empt ethical and legal challenges that often stall data‑driven projects. The research suggests that a governance model that actively solicits patient feedback, provides regular updates on data usage, and ensures equitable access to research outcomes will likely achieve higher participation rates and smoother cross‑border data flows.

For industry and policymakers, the Belgian findings serve as a practical blueprint for scaling patient‑centric data practices throughout Europe. Companies developing oncology therapies can leverage these insights to design data‑sharing agreements that align with patient expectations, thereby reducing compliance friction and accelerating clinical trial timelines. Ultimately, aligning the EHDS with patient‑valued principles not only strengthens public confidence but also fuels a more resilient, innovation‑ready health research landscape across the continent.